Improving Breast Cancer Treatment with Imaging
Project 2: Non-invasive imaging metrics to optimize early treatment switching decisions and prognostic modeling of long-term outcomes
This research helps doctors use imaging and other tests to choose the best breast cancer treatment for each patient.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11125945 on NIH RePORTER |
What this research studies
We are working to make sure every breast cancer patient has the best chance of a complete response to treatment. This involves using advanced imaging, tissue analysis, and biological markers to guide treatment decisions. Specifically, we are improving how MRI scans measure tumor changes to help doctors decide if a patient's treatment should be adjusted early on. This work builds on the I-SPY2.2 clinical trial design, aiming to personalize care.
Who could benefit from this research
Good fit: Patients with breast cancer who are undergoing treatment and receiving MRI scans would be ideal candidates for this type of guided care.
Not a fit: Patients whose breast cancer treatment does not involve imaging or those not participating in trials like I-SPY2.2 may not directly benefit from this specific approach.
Why it matters
Potential benefit: If successful, this work could lead to more personalized and effective breast cancer treatments, potentially improving long-term outcomes for patients.
How similar studies have performed: This work builds upon findings from previous I-SPY2 trials and retrospective studies, which have informed refinements to MRI protocols.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Hylton-Watson, Nola M. — University of California, San Francisco
- Study coordinator: Hylton-Watson, Nola M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.